Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collectionsSergio Marchini, Maurizio D’Incalci|The Lancet Oncology|2011Cited by 178
Trabectedin for Women With Ovarian Carcinoma After Treatment With Platinum and Taxanes FailsCristiana Sessa, Nicoletta Colombo, Antonella Perotti et al.|Journal of Clinical Oncology|2005Cited by 164
Increased sensitivity to platinum drugs of cancer cells with acquired resistance to trabectedinBenedetta Colmegna, Maurizio D’Incalci|British Journal of Cancer|2015Cited by 43
Inhibition of tumor‐associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti‐PD‐1 therapyCristina Belgiovine, Maurizio D’Incalci|European Journal of Immunology|2021Cited by 35
Tumor treating fields affect mesothelioma cell proliferation by exerting histotype-dependent cell cycle checkpoint activations and transcriptional modulationsLaura Mannarino, Maurizio D’Incalci|Cell Death and Disease|2022Cited by 8